Wang H, Bata B, Currie Z, Salvi S, Tan J. Systemic acitretin in the management of periocular squamous cell carcinoma.
BMJ Case Rep 2021;
14:14/4/e241167. [PMID:
33883116 PMCID:
PMC8061867 DOI:
10.1136/bcr-2020-241167]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
We report a case of periocular squamous cell carcinoma invading the anterior orbit that significantly reduced in size and regressed from invasive to in situ following treatment with oral acitretin, a second-generation retinoid. The residual in situ disease was then successfully treated with cryotherapy and the patient remains in remission 12 months following cessation of systemic acitretin.
Collapse